Search Results

There are 15394 results for: content related to: Anti-Inflammatory Immune Therapy in Heart Disease

  1. Immune Modulatory Therapies in Heart Failure: Using Myocarditis to Gain Mechanistic Insights

    Heart Failure: Pharmacologic Management

    Grace Chan, Koichi Fuse, Mei Sun, Bill Ayach, Peter P. Liu, Pages: 174–186, 2007

    Published Online : 16 NOV 2007, DOI: 10.1002/9780470994740.ch12

  2. You have free access to this content
    Novel Therapies for Heart Failure: Focus on Anti-Inflammatory Strategies

    Congestive Heart Failure

    Volume 12, Issue 3, May/June 2006, Pages: 153–161, Kumudha Ramasubbu, Guilherme Oliveira and Guillermo Torre-Amione

    Version of Record online : 29 JAN 2007, DOI: 10.1111/j.1527-5299.2006.04790.x

  3. You have free access to this content
    Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology

    European Journal of Heart Failure

    Volume 11, Issue 2, February 2009, Pages: 119–129, Stephane Heymans, Emilio Hirsch, Stefan D. Anker, Pal Aukrust, Jean-Luc Balligand, Jan W. Cohen-Tervaert, Helmut Drexler, Gerasimos Filippatos, Stephan B. Felix, Lars Gullestad, Denise Hilfiker-Kleiner, Stefan Janssens, Roberto Latini, Gitte Neubauer, Walter J. Paulus, Burkert Pieske, Piotr Ponikowski, Blanche Schroen, Heinz-Peter Schultheiss, Carsten Tschöpe, Marc van Bilsen, Faiez Zannad, John McMurray and Ajay M. Shah

    Version of Record online : 28 JAN 2009, DOI: 10.1093/eurjhf/hfn043

  4. You have full text access to this OnlineOpen article
    Drug-like actions of autoantibodies against receptors of the autonomous nervous system and their impact on human heart function

    British Journal of Pharmacology

    Volume 166, Issue 3, June 2012, Pages: 847–857, LR Herda, SB Felix and F Boege

    Version of Record online : 8 MAY 2012, DOI: 10.1111/j.1476-5381.2012.01828.x

  5. Reduction of Plasma Levels of Soluble Tumor Necrosis Factor and Interleukin-2 Receptors by Means of a Novel Immunoadsorption Column

    Therapeutic Apheresis and Dialysis

    Volume 12, Issue 6, December 2008, Pages: 491–499, Meredith Lentz and Kiran Kumar

    Version of Record online : 30 DEC 2008, DOI: 10.1111/j.1744-9987.2008.00640.x

  6. Immunomodulating Therapy in Chronic Heart Failure

    Immune Dysfunction and Immunotherapy in Heart Disease

    Lars Gullestad, Jan Kristian Damås, Arne Yndestad, Pål Aukrust, Pages: 97–108, 2008

    Published Online : 15 APR 2008, DOI: 10.1002/9780470692325.ch10

  7. The use of therapeutic apheresis in cardiovascular disease

    Transfusion Medicine

    Volume 24, Issue 2, April 2014, Pages: 68–78, O. Pignalosa, T. Infante and C. Napoli

    Version of Record online : 20 FEB 2014, DOI: 10.1111/tme.12103

  8. Synthesis of hepcidin derivatives in order to develop standards for immune adsorption method

    Journal of Peptide Science

    Volume 15, Issue 4, April 2009, Pages: 285–295, Ádám Balogh, Kata Horváti, Gábor Mező, László Derzbach, Beáta Szebeni, Lajos Nagy, József Prechl, Barna Vásárhelyi, Ferenc Hudecz and Szilvia Bősze

    Version of Record online : 2 FEB 2009, DOI: 10.1002/psc.1113

  9. Therapeutic plasma exchange a potential strategy for patients with advanced heart failure

    Journal of Clinical Apheresis

    Volume 25, Issue 6, 2010, Pages: 323–330, Guillermo Torre-Amione, Carlos M. Orrego, Nashwa Khalil, Christian Kottner-Assad, Christopher Leveque, Rene Celis, Keith A. Youker and Jerry D. Estep

    Version of Record online : 24 SEP 2010, DOI: 10.1002/jca.20264

  10. You have free access to this content
    Targeting anti-beta-1-adrenergic receptor antibodies for dilated cardiomyopathy

    European Journal of Heart Failure

    Volume 15, Issue 7, July 2013, Pages: 724–729, Priyesh A. Patel and Adrian F. Hernandez

    Version of Record online : 27 JAN 2014, DOI: 10.1093/eurjhf/hft065

  11. Effects of Immunoadsorption on the nt-BNP and nt-ANP Plasma Levels of Patients Suffering From Dilated Cardiomyopathy

    Therapeutic Apheresis and Dialysis

    Volume 10, Issue 1, February 2006, Pages: 42–48, Alexander Staudt, Yvonne Staudt, Astrid Hummel, Klaus Empen, Marcus Dörr, Christiane Trimpert, Katrin Birkenmeier, Uwe Kühl, Michel Noutsias, Dirk Russ and Stephan B Felix

    Version of Record online : 20 MAR 2006, DOI: 10.1111/j.1744-9987.2006.00343.x

  12. Immune Mechanisms in Pediatric Cardiovascular Disease

    Immune Dysfunction and Immunotherapy in Heart Disease

    Wendy A. Luce, Mandar S. Joshi, Timothy M. Hoffman, Timothy F. Feltes, John Anthony Bauer, Pages: 6–16, 2008

    Published Online : 15 APR 2008, DOI: 10.1002/9780470692325.ch2

  13. Heart Failure

    Cardiovascular Genetics and Genomics for the Cardiologist

    Markus Meyer, Peter VanBuren, Pages: 137–165, 2008

    Published Online : 15 APR 2008, DOI: 10.1002/9780470691977.ch7

  14. The Role of Cardiac Restraint Devices in the Treatment of Patients with Dilated Cardiomyopathy

    Heart Failure: Device Management

    Arthur M. Feldman, Pages: 59–67, 2009

    Published Online : 12 NOV 2009, DOI: 10.1002/9781444314427.ch5

  15. You have free access to this content
    Oral Abstracts

    American Journal of Transplantation

    Volume 11, Issue s2, April 2011, Pages: 28–211,

    Version of Record online : 4 APR 2011, DOI: 10.1111/j.1600-6143.2011.03533.x

  16. You have free access to this content
    Potential of mesenchymal stem cells as immune therapy in solid-organ transplantation

    Transplant International

    Volume 22, Issue 4, April 2009, Pages: 365–376, Meindert Crop, Carla Baan, Willem Weimar and Martin Hoogduijn

    Version of Record online : 3 NOV 2008, DOI: 10.1111/j.1432-2277.2008.00786.x

  17. Cerebrospinal fluid JC virus antibody index for diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy

    Annals of Neurology

    Volume 76, Issue 6, December 2014, Pages: 792–801, Clemens Warnke, Gloria von Geldern, Philipp Markwerth, Thomas Dehmel, Robert Hoepner, Ralf Gold, Michael Pawlita, Tania Kümpfel, Mathias Mäurer, Martin Stangel, Florian Wegner, Reinhard Hohlfeld, Vera Straeten, Volker Limmroth, Thomas Weber, Derik Hermsen, Christoph Kleinschnitz, Hans-Peter Hartung, Mike P. Wattjes, Anders Svenningson, Eugene Major, Tomas Olsson, Bernd C. Kieseier and Ortwin Adams

    Version of Record online : 8 MAY 2014, DOI: 10.1002/ana.24153

  18. Engineering immune therapy against hepatitis B virus

    Hepatology Research

    Volume 37, Issue s3, October 2007, Pages: S351–S356, Fazle Akbar, Osamu Yoshida, Masanori Abe, Yoichi Hiasa and Morikazu Onji

    Version of Record online : 10 OCT 2007, DOI: 10.1111/j.1872-034X.2007.00251.x

  19. Low over-expression of TNFα in the mouse heart increases contractile performance via TNFR1

    Journal of Cellular Biochemistry

    Volume 105, Issue 1, 1 September 2008, Pages: 99–107, Ilka Pinz, Stephen D. Wax, Paul Anderson and Joanne S. Ingwall

    Version of Record online : 1 MAY 2008, DOI: 10.1002/jcb.21798

  20. You have free access to this content
    Targeting Fibrosis for the Treatment of Heart Failure: A Role for Transforming Growth Factor-β

    Cardiovascular Therapeutics

    Volume 30, Issue 1, February 2012, Pages: e30–e40, Amanda J Edgley, Henry Krum and Darren J Kelly

    Version of Record online : 23 SEP 2010, DOI: 10.1111/j.1755-5922.2010.00228.x